ATHA - Athira Pharma, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	oc	Own	H
7/2/25 16:35	6/30/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Church Kevin	WA	O	Chief Sc	2	M.d	3	0.0554	45	37	169	D
7/2/25 16:35	7/1/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Church Kevin	WA	O	Chief Sc	2	S.d	-3	0.0554	-45		169	D
7/2/25 16:34	6/30/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Litton Mark James	WA	DO	P,CEO	2	M.d	7	0.0553	133	63	345	D
7/2/25 16:34	7/1/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Litton Mark James	WA	DO	P,CEO	2	S.d	-7	0.0553	-133		345	D
7/2/25 16:33	6/30/25	ATHA	Health	BioPrd	Biological Products, (No Diag	San Martin Javier	WA	O	CHIEF ME	2	M.d	3	0.0553	58	406	72	D
7/2/25 16:33	7/1/25	ATHA	Health	BioPrd	Biological Products, (No Diag	San Martin Javier	WA	O	CHIEF ME	2	S.d	-3	0.0553	-58		72	D
7/2/25 16:33	6/30/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Worthington Mark	WA	O	GC,CCO	2	M.d	3	0.0554	45	68	112	D
7/2/25 16:33	7/1/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Worthington Mark	WA	O	GC,CCO	2	S.d	-3	0.0554	-45		112	D
7/2/25 16:32	6/30/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Renninger Robert	WA	O	SVP,Fina	2	M.d	1	0.0557	15	16	109	D
7/2/25 16:32	7/1/25	ATHA	Health	BioPrd	Biological Products, (No Diag	Renninger Robert	WA	O	SVP,Fina	2	S.d	-1	0.0557	-15		109	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person